C79.31 ICD 10 Code is a billable and specific code that can be used to indicate a diagnosis of Secondary malignant neoplasm of brain for reimbursement purposes. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.
Possible back-references that may be applicable or related to C79.31 ICD10 Code:
- C00-D49 Neoplasms
- C76-C80 Malignant neoplasms of ill-defined, other secondary and unspecified sites
- C79 Secondary malignant neoplasm of other and unspecified sites
- C79.0 Secondary malignant neoplasm of kidney and renal pelvis
- C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
- C79.3 Secondary malignant neoplasm of brain and cerebral meninges
- C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
- C79.5 Secondary malignant neoplasm of bone and bone marrow
- C79.6 Secondary malignant neoplasm of ovary
- C79.7 Secondary malignant neoplasm of adrenal gland
- C79.8 Secondary malignant neoplasm of other specified sites
Present On Admission (POA Exempt)
C79.31 ICD 10 code is considered exempt from POA reporting
Clinical information about C79.31 ICD 10 code
A brain tumor is a growth of abnormal cells in the tissues of the brain. Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly. Some are primary brain tumors, which start in the brain. Others are metastatic, and they start somewhere else in the body and move to the brain.
Brain tumors can cause many symptoms. Some of the most common are:
- Headaches, often in the morning
- Nausea and vomiting
- Changes in your ability to talk, hear, or see
- Problems with balance or walking
- Problems with thinking or memory
- Feeling weak or sleepy
- Changes in your mood or behavior
- Seizures
Doctors diagnose brain tumors by doing a neurologic exam and tests including an MRI, CT scan, and biopsy. Treatment options include watchful waiting, surgery, radiation therapy, chemotherapy, and targeted therapy. Targeted therapy uses drugs or other substances that attack cancer cells with less harm to normal cells. Many people get a combination of treatments.
NIH: National Cancer Institute
The information in this box was provided by MedlinePlus.gov